SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors react to a significant $2 million insider share purchase by board directors and a double earnings beat that led to upward revenue guidance adjustments. While some community members remain frustrated by the stock's long-term price stagnation, others are highlighting the company's dividend yield and defensive positioning as attractive relative to broader market volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as market participants weigh persistent concerns over rising global bond yields and geopolitical tensions in the Middle East against ongoing AI infrastructure capital expenditure. Community sentiment remains deeply divided, with traders closely monitoring key support levels and dealer gamma positioning while debating whether the current pullback represents a healthy consolidation or a systemic credit risk.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors digest the positive long-term impact of a major settlement with Samsung and anticipate further licensing deals with memory industry peers. The community is actively discussing the pressure this creates for Micron, potential upcoming Federal Circuit developments, and the stock's transition from a long-running legal battle to a potential leader in AI-essential memory technology.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as investors reassess broad-market exposure amid ongoing debates over U.S. economic stability, shifting interest rate expectations, and the sustainability of high-valuation tech-driven growth. Community discourse remains centered on whether broad index funds provide a necessary buffer against sector-specific volatility or if targeted growth strategies offer better protection in the current macroeconomic environment.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors react to a rival $37.50 per share buyout bid from an Israeli firm, which surpasses the existing $35 offer from Hapag-Lloyd and potentially bypasses national security concerns regarding the state's 'golden share.' Community discussion is buzzing over the possibility of a bidding war, the potential for continued dividend distributions during the buyout period, and strong underlying shipping fundamentals.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing heightened scrutiny as community discussions weigh strong revenue growth and expanded institutional backing against ongoing concerns regarding high cash burn and potential further dilution. Investors are actively debating the company's long-term commercial potential and management execution while monitoring the stock's recent volatility following a capital raise.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are closely debating potential downside risks and a possible correction, driven by concerns over rising bond yields, energy costs, and geopolitical uncertainty in the Strait of Hormuz. Community sentiment is deeply divided, with traders focused on whether recent trade-related news will act as a temporary floor or if the index is setting up for a significant test of lower support levels.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing significant investor attention due to aggressive institutional interest in long-term call options, reinforcing the bullish narrative surrounding its critical role in supplying gas turbines and grid infrastructure for AI data centers. While the stock has experienced recent volatility and pullback, the community remains heavily focused on the company's record backlog, robust free cash flow, and its status as a foundational beneficiary of the multi-year AI power infrastructure buildout.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is attracting strong attention as investors rotate into value-oriented pharmaceutical stocks, driven by solid earnings performance and successful pipeline execution. The community is actively discussing the company's growth portfolio performance, potential acquisition strategies, and its defensive positioning compared to higher-volatility sectors.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems shares are experiencing significant volatility following a mixed earnings report where revenue fell short of consensus expectations despite raised full-year guidance. Investors are actively debating the company's valuation, the impact of upcoming share lock-up expirations, and the sustainability of its growth trajectory in the competitive AI hardware landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intuitive Surgical Stock Is Having Its Worst Year Since 2008. What's Behind the Sell-Off?

Key PointsIntuitive's revenue growth came in at 19% in its most recent quarter...

Is ISRG's Software Strategy Becoming as Important as Its Robots?

ISRG's software roadmap is strengthening da Vinci 5, with new features, renewals and recurring service revenues reinforcing its digital ecosystem.

HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up 

Haemonetics raises fiscal 2027 revenue guidance after Q1 earnings and sales beat, supported by Plasma growth and stronger cash generation.

Is SYK Worth Buying as Growth Improves but Execution Risks Persist?

Stryker's stronger growth, margin gains and product pipeline support the case, but cyber costs, supply constraints and acquisition execution keep risks elevated.

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.

National Vision Stock Down Despite Q2 Earnings & Revenue Beat

EYE beats Q2 earnings and revenue estimates, expands operating margin and raises its 2026 profit outlook despite gross margin pressure.

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too...

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

$ISRG Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.31 up 25.54% YoY
• Reported revenue of $2.89B up 18.54% YoY
• Intuitive Surgical expects worldwide da Vinci procedure growth of 13.5% to 15.5% in 2026, with non-GAAP gross profit margin between 68.0% and 69.0% and non-GAAP operating expense growth of 11% to 13%.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Why Did PEGA, ISRG, MCD Stocks Plunge To 52-Week Lows Today? 

Equity

Bearish Sentiment

$NBIS

$APLD

$AMD

$ISRG

$NBIS, $APLD, $AMD, and $ISRG are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish on? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $NBIS, $APLD, $AMD, or $ISRG?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ISRGIntuitive Surgical Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest ISRG News